Methyl 3-aminosulfonylthiophene-2-carboxylate

We are Methyl 3-aminosulfonylthiophene-2-carboxylate CAS:59337-93-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 59337-93-8
Product Name: Methyl 3-aminosulfonylthiophene-2-carboxylate
Other Name:
Methyl 3-aminosulfonylthiophene-2-carboxylate
Methyl 3-sulfamoyl-2-thiophenecarboxylate
Methyl 3-sulfamoylthiophene-2-carboxylate
Methyl 3-(aminosulfonyl)-2-thiophenecarboxylate
Methyl 3-(aminosulfonyl)thiophene-2-carboxylate
 
Density: 1.5±0.1 g/cm3
Boiling Point: 428.3±55.0 °C at 760 mmHg
Molecular Formula: C6H7NO4S2
Molecular Weight: 221.254
Flash Point: 212.8±31.5 °C
Exact Mass: 220.981644
PSA: 123.08000
LogP: -0.09
Vapour Pressure: 0.0±1.0 mmHg at 25°C
Index of Refraction: 1.579
 
Specification
Appearance: Light Yellow powder
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Thifensulfuron CAS: 79277-67-1.
Be used as pesticide intermediate, mainly used in the synthesis of the herbicide Thifensulfuron.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Methyl 3-aminosulfonylthiophene-2-carboxylate


Related News: The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.Cloruro de boro – N, N-dimetilmetamina CAS:1516-55-8 Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.2179-57-9 The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.2,4-Diamino phenetole sulfate The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.

Related Products
Product Name
2-N-Cyclopropylamino-4,6-DichloroTriazine View Details
TRIFLUOROACETALDEHYDE HYDRATE, 75% AQ. SOL. View Details
4-Ethyl-5-fluoro-6-hydroxypyrimidine View Details
Methyl 4-formylcinnamate manufacturer N-(2-Pyridyl)bis(trifluoromethanesulfonimide) Cas:145100-50-1 manufacturer 4-CHLORO-α-(METHYLAMINO)BENZENE ACETIC ACID manufacturer 9′-phenyl-9H,9’H-2,3′-bicarbazole manufacturer Dimethyl nonanedioate manufacturer